Literature DB >> 16335531

Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.

Nerea Allende-Vega1, Sylvia Dias, Diane Milne, David Meek.   

Abstract

The Murine double-minute clone 2 (Mdm2) onco-protein is the principal regulator of the tumour suppressor, p53. Mdm2 acts as an E3-type ubiquitin ligase that mediates the ubiquitylation and turnover of p53 under normal, unstressed circumstances. In response to cellular stress, such as DNA damage, the Mdm2-p53 interaction is disrupted. Part of the mechanism of uncoupling p53 from Mdm2-mediated degradation involves hypo-phosphorylation of a cluster of phosphorylated serine residues in the central acidic domain of Mdm2. Here, we show that two of the residues within this domain that are phosphorylated in vivo, Ser-260 and Ser-269, are phosphorylated by CK2 in vitro. Treatment of cells with the CK2 inhibitor, 4,5,6,7-tetrabromo-2-azabenzimidazole (TBB), leads to the induction of p53 and downstream targets of p53 including Mdm2 itself and p21. These data are consistent with the idea that CK2-mediated phosphorylation of Mdm2 may regulate Mdm2-mediated p53 turnover.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16335531     DOI: 10.1007/s11010-005-3074-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

Review 1.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  Critical contribution of the MDM2 acidic domain to p53 ubiquitination.

Authors:  Hidehiko Kawai; Dmitri Wiederschain; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 3.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 4.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

5.  A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

Authors:  D M Keller; X Zeng; Y Wang; Q H Zhang; M Kapoor; H Shu; R Goodman; G Lozano; Y Zhao; H Lu
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

6.  The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.

Authors:  T Léveillard; B Wasylyk
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  Identification of a CK2 phosphorylation site in mdm2.

Authors:  C Götz; S Kartarius; P Scholtes; W Nastainczyk; M Montenarh
Journal:  Eur J Biochem       Date:  1999-12

8.  Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

Authors:  S Sarno; H Reddy; F Meggio; M Ruzzene; S P Davies; A Donella-Deana; D Shugar; L A Pinna
Journal:  FEBS Lett       Date:  2001-05-04       Impact factor: 4.124

9.  Phosphorylation of yeast TBP by protein kinase CK2 reduces its specific binding to DNA.

Authors:  E Maldonado; J E Allende
Journal:  FEBS Lett       Date:  1999-01-29       Impact factor: 4.124

Review 10.  p53-independent functions of MDM2.

Authors:  Gitali Ganguli; Bohdan Wasylyk
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

View more
  11 in total

Review 1.  DNA-PK: a dynamic enzyme in a versatile DSB repair pathway.

Authors:  Anthony J Davis; Benjamin P C Chen; David J Chen
Journal:  DNA Repair (Amst)       Date:  2014-03-27

2.  Identification of novel CK2 inhibitors with a benzofuran scaffold by novel non-radiometric in vitro assays.

Authors:  Andreas Gratz; Uwe Kuckländer; Ricardo Bollig; Claudia Götz; Joachim Jose
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

3.  Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Authors:  Nerea Allende-Vega; Lynsey McKenzie; David Meek
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

4.  Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Authors:  Michael I Carr; Stephen N Jones
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

Review 5.  Regulation of MDM2 Stability After DNA Damage.

Authors:  Jiaqi Li; Manabu Kurokawa
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

6.  Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.

Authors:  D Dixit; V Sharma; S Ghosh; V S Mehta; E Sen
Journal:  Cell Death Dis       Date:  2012-02-09       Impact factor: 8.469

7.  CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.

Authors:  Na Zhao; Chen Wang; Peng Guo; Jun Hou; Hong Yang; Ting Lan; Yehan Zhou; Jiayu Li; Ujjal K Bhawal; Yang Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway.

Authors:  Abrar Ul Haq Khan; Nerea Allende-Vega; Delphine Gitenay; Sabine Gerbal-Chaloin; Claire Gondeau; Dang-Nghiem Vo; Sana Belkahla; Stefania Orecchioni; Giovanna Talarico; Francesco Bertolini; Milica Bozic; Jose M Valdivielso; Fabienne Bejjani; Isabelle Jariel; Isabel C Lopez-Mejia; Lluis Fajas; Charles-Henri Lecellier; Javier Hernandez; Martine Daujat; Martin Villalba
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 9.  Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2.

Authors:  Zaira Spinello; Anna Fregnani; Laura Quotti Tubi; Livio Trentin; Francesco Piazza; Sabrina Manni
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

10.  Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.

Authors:  Qiu-Xia Liang; Zhen-Bo Wang; Fei Lin; Chun-Hui Zhang; Hong-Mei Sun; Liang Zhou; Qian Zhou; Heide Schatten; Filhol-Cochet Odile; Boldyreff Brigitte; Qing-Yuan Sun; Wei-Ping Qian
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.